全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

基于网络生物学方法的中药药理作用机制研究思考与探索

Keywords: 网络生物学,系统生物学,中药药理作用机制

Full-Text   Cite this paper   Add to My Lib

Abstract:

中药复方多成分、多靶点协同作用的药理作用机制研究是中药现代化和国际化的"瓶颈"之一。近年出现的网络生物学研究方法为中药复方药理作用机制系统研究提供重要而有效的新思路、新模式。本文介绍了网络生物学研究的数学基础、论述了网络生物学在中药药理作用机制研究中的可行性,并提出了网络生物学在中药药理作用机制方面的研究思路。网络生物学可望为中药药理作用机制研究奠定理论基础,指导中药复方药物的开发,更好地继承和发扬祖国中医药学理论。

References

[1]  Verpoorte R, Crommelin D, Danhof M, et al. Commentary: "a systems view on the future of medicine: inspiration from Chinese medicine?"[J]. J Ethnopharmacol, 2009, 121 (3): 479.
[2]  Li P, Yang L P, Gong Y W. Application of systems biology technology in research of traditional Chinese medicine[J]. J Trad Chin Med, 2009, 29 (2): 153.
[3]  Schmidt B M, Ribnicky D M, Lipsky P E, et al. Revisiting the ancient concept of botanical therapeutics[J]. Nat Chem Biol, 2007, 3 (7): 360.
[4]  Barabasi A L, Oltvai Z N. Network biology: understanding the cell\'s functional organization[J]. Nat Rev Genet, 2004, 5 (2): 101.
[5]  Sengupta U, Ukil S, Dimitrova N, et al. Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications[J]. PloS One, 2009, 4 (12):e8100.
[6]  Lee D, Hwang S, Son S W, et al. A protein interaction network associated with asthma[J]. J Theor Biol, 2008, 252 (4):722.
[7]  Chen B S, Chu L H. Construction of a cancer-perturbed protein-protein interaction network for discovery of apoptosis drug targets[J]. Bmc Syst Biol, 2008,2:56.
[8]  Nielsen U B, Schoeberl B, Pace E A, et al. Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis[J]. Sci Signal, 2009, 2 (77):ra33.
[9]  Li S, Zhao S W. Network-based relating pharmacological and genomic spaces for drug target identification[J]. PloS One, 2010, 5 (7):e11597.
[10]  Hopkins A L. Network pharmacology: the next paradigm in drug discovery[J]. Nat Chem Biol, 2008, 4 (11): 682.
[11]  Xu X J, Zhu W, Qiu X H, et al. Computational network pharmacological research of Chinese medicinal plants for chronic kidney disease[J]. Sci China Chem, 2010, 53 (11): 2337.
[12]  罗国安,梁琼麟,王义明,等. 中医药系统生物学发展及展望[J]. 中国天然药物, 2009, 7 (4):242.
[13]  Morphy R,Rankovic Z. Fragments, network biology and designing multiple ligands[J]. Drug Discov Today, 2007, 12 (3/5):156.
[14]  Li S. Network systems underlying traditional Chinese medicine syndrome and herb formula[J]. Curr Bioinform, 2009, 4 (3):188.
[15]  梁逸曾,余雁,易智彪,等. 代谢组学与中药现代化[J]. 中国医学科学院学报,2007, 29 (6):823.
[16]  Watts D J, Strogatz S H. Collective dynamics of \'small-world\' networks[J]. Nature, 1998, 393 (6684): 440.
[17]  Barabasi A L, Albert R. Emergence of scaling in random networks[J]. Science, 1999, 286 (5439):509.
[18]  Newman M E J. The structure and function of complex networks[J]. Siam Rev, 2003, 45(2): 167.
[19]  Ideker T, Galitski T, Hood L. A new approach to decoding life: systems biology[J]. Annu Rev Genomics Hum Genet, 2001, 2:343.
[20]  Wang L, Zhou G B, Liu P, et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia[J]. Proc Natl Acad Sci USA, 2008, 105 (12):4826.
[21]  Chen M J, Su M M, Zhao L P, et al. Metabonomic study of aristolochic acid-induced nephrotoxicity in rats[J]. J Proteome Res, 2006, 5 (4): 995.
[22]  Chen M J, Zhao L P, Jia W. Metabonomic study on the biochemical profiles of a hydrocortisone-induced animal model[J]. J Proteome Res,2005, 4 (6): 2391.
[23]  Wang X Y, Su M M, Qiu Y P, et al. Metabolic regulatory network alterations in response to acute cold stress and ginsenoside intervention[J]. J Proteome Res, 2007, 6 (9):3449.
[24]  Auffray C, Chen Z, Hood L. Systems medicine: the future of medical genomics and healthcare[J]. Genome Med, 2009, 1(1):1.
[25]  王金晶,钱夕元,罗国安. 双龙方有效成分诱导干细胞分化过程中差异表达基因的筛选和聚类分析[J]. 世界科学技术--中医药现代化, 2007, 9 (3):39.
[26]  Barabási A L, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease[J]. Nat Rev Genet, 2011, 12 (1):56.
[27]  Stelzl U, Worm U, Lalowski M, et al. A human protein-protein interaction network: A resource for annotating the proteome[J]. Cell, 2005, 122 (6):957.
[28]  Lee S, Park K, Kim D. Building a drug-target network and its applications[J]. Expert Opinion on Drug Discovery, 2009, 4 (11):1177.
[29]  Yildirim M A, Goh K I, Cusick M E, et al. Drug-target network[J]. Nat Biotechnol, 2007, 25 (10): 1119.
[30]  Goh K I, Cusick M E, Valle D, et al. The human disease network[J]. Proc Natl Acad Sci USA, 2007, 104 (21): 8685.
[31]  Lee D S, Park J, Kay K A, et al. The implications of human metabolic network topology for disease comorbidity[J]. Proc Natl Acad Sci USA,2008, 105 (29): 9880.
[32]  Jeong H, Tombor B, Albert R, et al. The large-scale organization of metabolic networks[J]. Nature, 2000, 407 (6804):651.
[33]  Ma H W, Goryanin I. Human metabolic network reconstruction and its impact on drug discovery and development[J]. Drug Disc Today, 2008, 13 (9/10):402.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133